Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

397
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
397

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of MRI-Based vs Clinical T Staging in Localized Prostate Cancer.

JAMA network open·2026
Same author

Clinical significance of MRI PI-RADS 3 lesions upgraded by dynamic contrast enhancement: the "PI-RADS 3 + 1" subgroup.

International urology and nephrology·2026
Same author

From fossil to bio-circular plastics: the environmental benefits of bio-attributed acrylonitrile butadiene styrene in single-use cystoscopes.

BJU international·2026
Same author

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

European urology·2026
Same authorSame journal

Evidence Thresholds for Novel Therapeutic Strategies in Prostate Cancer: A Consensus Statement from the Prostate Cancer Committee of the French Urological Association.

The French journal of urology·2026
Same author

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling.

European urology focus·2026

Related Experiment Video

Updated: Jun 26, 2025

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.0K

Is there a best timing for benign prostatic hyperplasia surgery?

Marc Fourmarier1, Michael Baboudjian2, Gregoire Robert3

  • 1Department of Urology, CH Aix-Pertuis, Aix-en-Provence, France.

The French Journal of Urology
|May 8, 2024
PubMed
Summary

The optimal timing for benign prostatic hyperplasia (BPH) surgery remains debated. While early surgery offers superior efficacy, medical therapy can avoid surgical risks in selected patients with lower urinary tract symptoms (LUTS).

Keywords:
5 alpha-reductase inhibitorsAlpha-blockerBenign prostatic hyperplasiaGreen lightHolepLaserLower urinary tract symptomsTransurethral resection of the prostate

More Related Videos

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.3K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.7K

Related Experiment Videos

Last Updated: Jun 26, 2025

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.0K
Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.3K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.7K

Area of Science:

  • Urology
  • Surgical Oncology
  • Geriatric Medicine

Background:

  • Medical therapy is now the primary treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
  • Surgical intervention for BPH is typically reserved for patients unresponsive to medical management or experiencing complications.
  • The optimal timing for surgical intervention in LUTS/BPH requires careful consideration.

Purpose of the Study:

  • To discuss the optimal timing for surgical management of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
  • To evaluate the evidence for and against early surgical treatment of BPH.

Main Methods:

  • A comprehensive literature search was conducted on PubMed/MEDLINE from January 1990 to January 2022.
  • MeSH terms included 'Lower Urinary Tract Symptoms', 'Prostatic Hyperplasia', 'Prostatic Hyperplasia/therapy', 'Prostatic Hyperplasia/complications', 'Treatment Outcome', and 'Time-to-Treatment'.
  • Evidence for early surgical treatment of BPH was analyzed and presented in a pros and cons format.

Main Results:

  • Arguments for early surgery highlight its superior efficacy and cost-effectiveness compared to medical treatment.
  • Early surgery may prevent worse postoperative outcomes associated with delayed intervention.
  • Arguments against early surgery emphasize the effectiveness of medical therapy in selected patients and the avoidance of surgical risks, including sexual side effects.

Conclusions:

  • Further clinical trials are needed to compare long-term outcomes of prolonged medical therapy versus early surgical treatment for BPH.
  • The optimal approach should consider the aging population and individual patient factors.
  • Patient involvement in treatment decisions is crucial.